Take Very Good
Care of YourselvesDeuteronomy 4:15

Exercise Nutrition Diabetes prevention
Children's health Diabetes Medications Research Updates Products & Trials
Diabetes Medications Cardiovascular /controlling Blood Sugars Continuous Glucose Monitoring
Research Updates Products & Trials    
Exercise
Exercise can slow diabetic peripheral neuropathy
http://linkinghub.elsevie...
Combined treatment with exercise training and acarbose improves metabolic control and cardiovascular risk factor profile in subjects with mild type 2 diabetes
http://care.diabetesjourn...
How short-term diet and exercise effect overweight children
http://linkinghub.elsevie...
Nutrition
New study published in diabetes care shows that supplementation with chromium picolinate significantly improves glycemic control and attenuates weight gain
http://linkinghub.elsevie...
High levels of certain pollutants in the body have been associated with an increased risk for diabetes. Further studies are needed to confirm the results
http://care.diabetesjourn...
Metabolic effects of spices, teas, and caffeine
http://blogs.healthcentra...
Diabetes prevention
New study seeks to lower diabetes risk in youth
see full article in our parents & children and medical news section.
http://www.eurekalert.org...
High levels of certain pollutants in the body have been associated with an increased risk for diabetes. Further studies are needed to confirm the results
http://care.diabetesjourn...
The national diabetes education program has designed a national awareness campaign to target people at risk for type 2 diabetes.
The campaign will create awareness that type 2 diabetes can be prevented through modest lifestyle changes and losing about 5 to 7 percent of body weight.
http://www.ndep.nih.gov/c...
Children's health
New study seeks to lower diabetes risk in youth
See full article in our parents & children and medical news section.
http://www.eurekalert.org...
How short-term diet and exercise effect overweight children
http://linkinghub.elsevie...
Diabetes Medications
Refrigerating insulin and Byetta
http://blogs.healthcentra...
Byetta (medication for t2 diabetes from Amylin pharmaceuticals and illy) is back
http://blogs.healthcentra...
Controlling nausea on Byetta
http://blogs.healthcentra...
Research Updates Products & Trials
Emisphere Completes Enrollment for Phase Ii Oral Insulin Clinical Trial
No Safety Concerns Raised to Date on Oral Insulin Product Company Receives Approval to Expand Study from 120 to 140 Patients
Emisphere provides update on use of the eligen(r) technology to enhance pulmonary delivery of proteins, including insulin
Emisphere has issued patents with claims directed to pulmonary delivery of peptides Pre-clinical data demonstrates high bioavailability Favorable safety profile Pulmonary delivery of insulin in combination with Emisphere carrier reduces the up-regulation of immune response genes Second generation inhaled insulin formulations demonstrating promise in clinical studies
http://www.emisphere.com/...
Diabetes Medications
Intensive insulin therapy reduces LDL (low-density lipoprotein) particles in patients with type 2 diabetes mellitus
http://linkinghub.elsevie...
Cardiovascular /controlling Blood Sugars
Effects of lifestyle modification and the influence on cardiovascular disease of type 2 diabetes
http://linkinghub.elsevie...
Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies
http://linkinghub.elsevie...
Combined treatment with exercise training and acarbose improves metabolic control and cardiovascular risk factor profile in subjects with mild type 2 diabetes
http://care.diabetesjourn...
Continuous Glucose Monitoring
Dexcom receives FDA approval for dmô consumer data manager
http://www.dexcom.com/htm...
Research Updates Products & Trials
Renal and cardiovascular complications of type 2 diabetes mellitus, can be hereditary
http://hyper.ahajournals....
Diamyd medical is focused on developing treatments for diabetes, both type 1 and type 2, via gad protein therapy
Its lead drug candidate, Diamydô, is designed to reduce the need of insulin injections and prevent the destruction of beta cells. furthermore, it may allow for regeneration of beta cells in a non-autoimmune environment, thus setting the stage for a cure of the disease.
Diamyd medicalís furthest developed project is Diamydô, which is currently employed in two ongoing clinical phase ii trials of both type 2 and type 1 diabetes. Other mainstream developments include using a proprietary nerve-target delivery system to deliver gad to treat diabetes pain and neuropathy.
http://www.diamyd.com/...